366 filings
Page 8 of 19
3
6r6ta3 j8gf
28 Sep 22
eFFECTOR Therapeutics / Mayank Gandhi ownership change
4:43pm
4
gdr8iustbosmggx0f
27 Sep 22
eFFECTOR Therapeutics / Christopher B Ehrlich ownership change
8:01am
424B3
lwe445fl
14 Sep 22
Prospectus supplement
8:22am
8-K
cnl 6s0nvyfj
14 Sep 22
Other Events
8:14am
EFFECT
7nwhlpn13xqhp
12 Sep 22
Notice of effectiveness
12:15am
EFFECT
9xeym1xmergvv
7 Sep 22
Notice of effectiveness
12:15am
UPLOAD
kq9k9 t0p7nage
7 Sep 22
Letter from SEC
12:00am
CORRESP
f5px955dvbrscjx8qug1
7 Sep 22
Correspondence with SEC
12:00am
424B3
qavl62k1hhreldm
1 Sep 22
Prospectus supplement
5:01pm
POS AM
0bd4mt4gv5s
1 Sep 22
Prospectus update (post-effective amendment)
4:54pm
8-K
ab7yfwfe5ge
1 Sep 22
Entry into a Material Definitive Agreement
4:30pm
S-3
xd6vy cjx
1 Sep 22
Shelf registration
4:02pm
SC 13D/A
g255ocehceqw
19 Aug 22
eFFECTOR Therapeutics / US VENTURE PARTNERS X ownership change
12:00am
SC 13D/A
ba1swhb j6x
19 Aug 22
eFFECTOR Therapeutics / US VENTURE PARTNERS X ownership change
12:00am
3
avkq q06l
11 Aug 22
eFFECTOR Therapeutics / Subsidiary Holdings L.L.C. CG ownership change
5:05pm
SC 13D/A
kcbi9 15apfj
11 Aug 22
eFFECTOR Therapeutics / Carlyle ownership change
4:55pm
8-K
cdq37s6hdiwzms7jhlll
9 Aug 22
Presented positive interim results at ASCO 2022 from ongoing zotatifin Phase 1/2 dose escalation and expansion trial
12:00am
424B3
sykj3en45mfpw8
9 Aug 22
Prospectus supplement
12:00am
424B3
s0pmy gfxnpuydj3
9 Aug 22
Prospectus supplement
12:00am